ScreenerHero

PPGN PolyPeptide Group AG

SWX · CH · Healthcare · Drug Manufacturers - Specialty & Generic · polypeptide.com
44.05CHF-0.11%Mkt Cap: 1.66B $P/E: 107.44

PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceut…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap1.66B USD
Enterprise Value1.76B USD
Revenue (TTM)523.70M USD
Gross Profit75.94M USD
Net Income (TTM)-24.16M USD
Revenue/Share14.06 CHF
Last Price44.05 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.5K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)107.44
P/E (Forward)30.56
PEG—
EV/EBITDA20.49
EV/Revenue3.37
P/S3.17
P/B4.38
EPS (TTM)0.41
EPS (Forward)1.44
52W Range
21.8079% of range50.10
52W High50.10 CHF
52W Low21.80 CHF
Profitability
Gross Margin16.98%
Oper. Margin9.29%
EBITDA Margin16.44%
Profit Margin-5.40%
ROE-6.22%
ROA-2.56%
Growth
Revenue Growth41.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF88.46M USD
CapEx (TTM)124.29M USD
FCF Margin-20.18%
FCF Yield-6.37%
Net Debt102.92M USD
Net Debt/EBITDA1.20
Balance Sheet
Debt/Equity0.38
Current Ratio1.64
Quick Ratio0.76
Book Value/Sh10.06 CHF
Cash/Share1.79 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CHF
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 28, 2022
Pay DateMay 2, 2022
Analyst Consensus
Rating—
Target (Mean)39.22 CHF
Upside (mean)-11.0%
Target Range25.78 CHF – 43.86 CHF
25.78-11.0% to mean43.86
# Analysts5
Ownership
Shares Out.33.02M
Float12.97M
Insiders60.52%
Institutions13.30%
Technical
SMA 5043.99 (+0.1%)
SMA 20035.87 (+22.8%)
Beta1.00
S&P 52W Chg14.58%
Avg Vol (30d)109.92K
Avg Vol (10d)60.42K
Technical Indicators
RSI (14)53.4
MACD0.0390
MACD Signal0.0436
MACD Hist.-0.0046
BB Upper44.18 CHF
BB Middle44.06 CHF
BB Lower43.95 CHF
BB Width0.53%
ATR (14)0.1409 CHF
Vol Ratio (20d)0.50x